Purigen Biosystems
Pleasanton
About Purigen Biosystems
Purigen Biosystems' innovative products offer a truly transformative solution for DNA and RNA purification. Their proprietary approach uses isotachophoresis to separate nucleic acids freely in solution without binding or stripping from a physical surface. Because of this, their technology is agnostic to nucleic acid size or sequence and delivers unbiased results ― even from the more challenging sample types like FFPE tissue or low cell counts. Their Ionic Purification System and Kits combine to provide researchers with a fast, efficient, and effective alternative for automated nucleic acid purification.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $93.1M
- Funding stage: M&A
- Last round: Series C (Apr 2021)
- Website: purigenbio.com
- Phone: 877-787-4436
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/purigen-biosystems-92385 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.